Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antimicrobial Coating for Medical Implants Offers Non-Drug Based Approach to Prevent Surgical Infections

By HospiMedica International staff writers
Posted on 14 Dec 2023

Non-elective surgeries, which are increasingly frequent, often involve patients with pre-existing medical conditions that heighten their risk of post-surgical infections. More...

One challenge in these scenarios is that patients may not immediately detect an infection stemming from their surgery. Current medical devices often utilize silver coatings as an infection deterrent. However, prolonged exposure to high levels of silver can lead to its accumulation in the body. Furthermore, silver coatings are unsuitable for certain load-bearing or supportive implanted devices. While drugs exist to combat infections, they are limited by their effective duration and potential side effects. Now, new research has led to the development of antibacterial material for internal medical devices that could help prevent infections.

A collaborative effort between Colorado State University (CSU, Fort Collins, CO, USA) and the University of St. Andrews (St. Andrews, Scotland) has resulted in an innovative and versatile antimicrobial material suitable for coating internal medical devices. This development combines prior research from both institutions on metal-organic frameworks. These are three-dimensional crystalline structures composed of metals and linkers, characterized by their porous nature and stability in water. The collaborative research successfully merged two distinct frameworks into a single, thin-film membrane capable of gradually emitting nitric oxide, a naturally occurring antimicrobial agent in the human body known for its prolonged and effective bacterial and fungal eradication capabilities.

For developing the thin-film material, the team experimented with three different membranes, each featuring varying combinations of metal-organic frameworks. Utilizing a novel cryogenic imaging technique, they were able to ascertain optimal ratios and methods for the sustained release of nitric oxide. Initial findings are encouraging, showing the material's effectiveness against common bacteria such as Staphylococcus and Escherichia coli. Impressively, even a minimal concentration of this material demonstrated significant antibacterial potency. This is a positive indicator of its practical application beyond laboratory settings. The research team is now focusing on refining the delivery mechanisms of this material and exploring its transition from thin-film form to a more universally applicable format. This advancement holds the potential to be effectively integrated into a wide range of medical devices, including pacemakers, enhancing patient safety and care in surgical and other medical contexts.

“Any implantable device is a candidate for this technology, and we think it will actually be inexpensive to manufacture,” said Chemistry Professor Melissa Reynolds, who led the work at CSU. “We haven’t found any limitations yet and are looking forward to working with companies to develop this approach.”

Related Links:
Colorado State University
University of St. Andrews


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.